Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|December 11, 2008
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trialG Huebner, H Link, C H Kohne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 11, 2020
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trialR Fietkau, R Grützmann, U A Wittel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM studyG Folprecht, C Pericay, M P Saunders, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'G Folprecht, M Morfouace, M Collienne, et al.
The British Journal of Surgery|August 20, 2019
Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trialB Garlipp, P Gibbs, G A Van Hazel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2015
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant RegistryR Adam, V Karam, V Delvart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2014
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetH Blons, J F Emile, K Le Malicot, et al.
The British Journal of Surgery|April 1, 2020
Consensus on definition and severity grading of lymphatic complications after kidney transplantationA Mehrabi, Y Kulu, M Sabagh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patientsJ Taieb, R Balogoun, K Le Malicot, et al.
Pageof 25